Skip to content

Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (CMTR2)

Homo sapiens — UniProt Q8IYT2

Gene: CMTR2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (CMTR2) is a protein from Homo sapiens identified by UniProt accession Q8IYT2, 770 residues long. MolForge cross-references it against 0 known binders and 32 disease associations.

  • UniProt accession: Q8IYT2; gene symbol CMTR2.
  • Organism: Homo sapiens.
  • Length: 770 amino acids.
  • Top disease associations (Open Targets): neurodegenerative disease, lung adenocarcinoma and neuroticism measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameCap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
UniProt accessionQ8IYT2
GeneCMTR2
OrganismHomo sapiens
Length770 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (32)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.54
  • lung adenocarcinoma · score 0.30
  • neuroticism measurement · score 0.28
  • non-small cell lung carcinoma · score 0.26
  • overall survival · score 0.22
  • mood instability measurement · score 0.20
  • adolescent idiopathic scoliosis · score 0.20
  • feeling tense measurement · score 0.18
  • pulse pressure measurement · score 0.07
  • haptoglobin measurement · score 0.04

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8IYT2-F1alphafoldPREDICTED85.86—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8IYT2.

Amino-acid sequence (770 residues)

MSKCRKTPVQ QLASPASFSP DILADIFELF AKNFSYGKPL NNEWQLPDPS EIFTCDHTEL NAFLDLKNSL NEVKNLLSDK KLDEWHEHTA FTNKAGKIIS HVRKSVNAEL CTQAWCKFHE ILCSFPLIPQ EAFQNGKLNS LHLCEAPGAF IASLNHYLKS HRFPCHWSWV ANTLNPYHEA NDDLMMIMDD RLIANTLHWW YFGPDNTGDI MTLKFLTGLQ NFISSMATVH LVTADGSFDC QGNPGEQEAL VSSLHYCEVV TALTTLGNGG SFVLKMFTMF EHCSINLMYL LNCCFDQVHV FKPATSKAGN SEVYVVCLHY KGREAIHPLL SKMTLNFGTE MKRKALFPHH VIPDSFLKRH EECCVFFHKY QLETISENIR LFECMGKAEQ EKLNNLRDCA IQYFMQKFQL KHLSRNNWLV KKSSIGCSTN TKWFGQRNKY FKTYNERKML EALSWKDKVA KGYFNSWAEE HGVYHPGQSS ILEGTASNLE CHLWHILEGK KLPKVKCSPF CNGEILKTLN EAIEKSLGGA FNLDSKFRPK QQYSCSCHVF SEELIFSELC SLTECLQDEQ VVVPSNQIKC LLVGFSTLRN IKMHIPLEVR LLESAELTTF SCSLLHDGDP TYQRLFLDCL LHSLRELHTG DVMILPVLSC FTRFMAGLIF VLHSCFRFIT FVCPTSSDPL RTCAVLLCVG YQDLPNPVFR YLQSVNELLS TLLNSDSPQQ VLQFVPMEVL LKGALLDFLW DLNAAIAKRH LHFIIQRERE EIINSLQLQN

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with CMTR2?

The strongest Open Targets associations for CMTR2 are neurodegenerative disease, lung adenocarcinoma, neuroticism measurement, non-small cell lung carcinoma and overall survival.

How long is the CMTR2 protein?

The Homo sapiens CMTR2 protein (UniProt Q8IYT2) is 770 amino acids long.

Browse: Targets: C · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8IYT2
GeneCMTR2
OrganismHomo sapiens
Length770
Binders0
Diseases32
View on UniProt